59 related articles for article (PubMed ID: 9602476)
1. Triple test screening for Down syndrome: an Egyptian-tailored study.
Abou-Youssef HS; Kamal MM; Mehaney DA
PLoS One; 2014; 9(10):e110370. PubMed ID: 25330176
[TBL] [Abstract][Full Text] [Related]
2. Correlation between maternal serum biomarkers and the risk of fetal chromosome copy number variants: a single-center retrospective study.
Zhang M; Gao Y; Liang M; Wang Y; Guo L; Wu D; Xiao H; Lin L; Wang H; Liao S
Arch Gynecol Obstet; 2024 May; ():. PubMed ID: 38814455
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Infection Increases High Risk Rate of Down Syndrome Screening Test by Reducing Alpha-Fetoprotein.
Zhang Z; Wang X; Li X; Huang Y; Zhou G; Ma Z; Li L; Di H; Li Y; Chen R; Xie Q; Mu Y
Clin Lab; 2024 May; 70(5):. PubMed ID: 38747909
[TBL] [Abstract][Full Text] [Related]
4. Could first- and second-trimester biochemical markers for Down syndrome have a role in predicting intrahepatic cholestasis of pregnancy?
Tayyar AT; Tayyar A; Atakul T; Yayla CA; Kilicci C; Eser A; Karakus R; Herkiloglu D; Cundubey CR; Tayyar M
Arch Med Sci; 2018 Jun; 14(4):846-850. PubMed ID: 30002703
[TBL] [Abstract][Full Text] [Related]
5. Can Serum Biomarker Values from Second-Trimester Aneuploidy Screening Predict the development of Retinopathy of Prematurity in Premature Infants?
Sabanci S; Kucuk MF; Savas HB; Suren E; Erol MK; Yavuz A; Sipahioglu H
Beyoglu Eye J; 2024; 9(2):95-100. PubMed ID: 38854900
[TBL] [Abstract][Full Text] [Related]
6. Hormonal evidence supports the theory of selection in utero.
Catalano RA; Saxton KB; Bruckner TA; Pearl M; Anderson E; Goldman-Mellor S; Margerison-Zilko C; Subbaraman M; Currier RJ; Kharrazi M
Am J Hum Biol; 2012; 24(4):526-32. PubMed ID: 22411168
[TBL] [Abstract][Full Text] [Related]
7. Dyslipidemia in pregnancy may contribute to increased risk of neural tube defects -a pilot study in north Indian population.
Gupta S; Arora S; Trivedi SS; Singh R
Indian J Clin Biochem; 2009 Apr; 24(2):150-4. PubMed ID: 23105824
[TBL] [Abstract][Full Text] [Related]
8. Very elevated hCGβ (≥10 multiple of the median) in maternal marker screening for Down syndrome: Frequency, etiologies, outcomes, and guidelines.
Dreux S; Rosenblatt J; Massardier J; Benachi A; Voirin-Mathieu E; ; Muller F
Prenat Diagn; 2024 May; ():. PubMed ID: 38757850
[TBL] [Abstract][Full Text] [Related]
9. Natural selection in utero induced by mass layoffs: the hCG evidence.
Catalano R; Margerison-Zilko C; Goldman-Mellor S; Pearl M; Anderson E; Saxton K; Bruckner T; Subbaraman M; Goodman J; Epstein M; Currier R; Kharrazi M
Evol Appl; 2012 Dec; 5(8):796-805. PubMed ID: 23346225
[TBL] [Abstract][Full Text] [Related]
10. First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012599. PubMed ID: 28295159
[TBL] [Abstract][Full Text] [Related]
11. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012600. PubMed ID: 28295158
[TBL] [Abstract][Full Text] [Related]
12. Two kinds of common prenatal screening tests for Down's syndrome: a systematic review and meta-analysis.
Yao Y; Liao Y; Han M; Li SL; Luo J; Zhang B
Sci Rep; 2016 Jan; 6():18866. PubMed ID: 26732706
[TBL] [Abstract][Full Text] [Related]
13. Urine tests for Down's syndrome screening.
Alldred SK; Guo B; Takwoingi Y; Pennant M; Wisniewski S; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011984. PubMed ID: 26662198
[TBL] [Abstract][Full Text] [Related]
14. First trimester serum tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011975. PubMed ID: 26617074
[TBL] [Abstract][Full Text] [Related]
15. A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States.
Walker BS; Nelson RE; Jackson BR; Grenache DG; Ashwood ER; Schmidt RL
PLoS One; 2015; 10(7):e0131402. PubMed ID: 26133556
[TBL] [Abstract][Full Text] [Related]
16. Second trimester serum tests for Down's Syndrome screening.
Alldred SK; Deeks JJ; Guo B; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2012 Jun; 2012(6):CD009925. PubMed ID: 22696388
[TBL] [Abstract][Full Text] [Related]
17. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
18. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
Rice JD; McIntosh SF; Halstead AC
Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
